CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,000 | -99.9% | 1,000 | -99.9% | 0.00% | – |
| Q3 2018 | $3,957,000 | -48.3% | 899,386 | -38.9% | 0.00% | -100.0% |
| Q2 2018 | $7,652,000 | +30.0% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,886,000 | -41.2% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,007,000 | -16.0% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $11,920,000 | +8.0% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $11,037,000 | -3.8% | 1,471,553 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,478,000 | -25.0% | 1,471,553 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $15,304,000 | -4.3% | 1,471,553 | +5.4% | 0.00% | 0.0% |
| Q3 2016 | $15,991,000 | +11.1% | 1,396,553 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $14,398,000 | -34.3% | 1,396,553 | -19.0% | 0.00% | -33.3% |
| Q1 2016 | $21,906,000 | -35.1% | 1,724,850 | -12.3% | 0.00% | -40.0% |
| Q4 2015 | $33,743,000 | +31.2% | 1,966,401 | -2.7% | 0.01% | +25.0% |
| Q3 2015 | $25,710,000 | -9.3% | 2,021,217 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $28,337,000 | – | 2,021,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,172,044 | $2,625,000 | 2.31% |
| Stonepine Capital Management, LLC | 782,817 | $1,754,000 | 0.80% |
| 5AM Venture Management, LLC | 1,134,511 | $2,541,000 | 0.52% |
| Omega Fund Management, LLC | 2,005,249 | $4,492,000 | 0.50% |
| BVF INC/IL | 4,776,904 | $10,700,000 | 0.42% |
| KNOTT DAVID M | 415,308 | $930,000 | 0.34% |
| West Family Investments, Inc. | 368,910 | $826,000 | 0.21% |
| Monashee Investment Management LLC | 369,099 | $827,000 | 0.15% |
| JEPPSON WEALTH MANAGEMENT, LLC | 60,100 | $134,000 | 0.07% |
| Ergoteles LLC | 160,070 | $359,000 | 0.01% |